These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11100005)

  • 1. Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.
    Campbell KR; Cantor W; Sketch M; Ohman EM
    Am Heart J; 2000 Dec; 140(6 Suppl):S115-24. PubMed ID: 11100005
    [No Abstract]   [Full Text] [Related]  

  • 2. GUSTO IV: expanding therapeutic options in acute coronary syndromes.
    Lincoff AM
    Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?
    Zeymer U
    J Thromb Thrombolysis; 2003 Apr; 15(2):91-7. PubMed ID: 14618075
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis.
    Cannon CP
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV37-43. PubMed ID: 10492852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction.
    Verheugt FW
    Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.
    Holper EM; Giugliano RP; Antman EM
    Coron Artery Dis; 1999 Dec; 10(8):567-73. PubMed ID: 10599535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
    Rebeiz AG; Johanson P; Green CL; Crater SW; Roe MT; Langer A; Giugliano RP; Lincoff AM; Newby LK; Harrington RA; Topol EJ; Califf RM; Wagner GS; Krucoff MW
    Am J Cardiol; 2005 Mar; 95(5):611-4. PubMed ID: 15721101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
    Campbell KR; Ohman EM; Cantor W; Lincoff AM
    Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
    van den Brand M; Ronner EF
    Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction.
    Vivekananthan DP; Patel VB; Moliterno DJ
    J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction.
    Dobesh PP; Kasiar JB
    Pharmacotherapy; 2002 Jul; 22(7):864-88. PubMed ID: 12126220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy for acute myocardial infarct].
    Nordt TK; Bode C
    Internist (Berl); 2001 May; 42(5):659-64. PubMed ID: 11400573
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction.
    Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G
    Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?
    Brener SJ
    J Am Coll Cardiol; 2009 May; 53(18):1674-6. PubMed ID: 19406343
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE; Roe MT
    J Invasive Cardiol; 2002 Sep; 14(9):565-74. PubMed ID: 12205361
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoprotein IIb/IIIa receptor antagonists in the treatment of acute ST elevation MI: from hypotheses to unexpected recent observations.
    Ross AM
    J Thromb Thrombolysis; 2003 Apr; 15(2):85-9. PubMed ID: 14618074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.